Beta Bionics (BBNX) Other financing activities (2024 - 2026)

Beta Bionics has disclosed Other financing activities across 3 years of filings, most recently posting $1.8 million for Q2 2026.

• In Q2 2026, Other financing activities changed N/A year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at $2.4 million (down 84.53% YoY), while the FY2025 annual figure was $15.6 million, up 17417.98% from the prior year.
• Other financing activities came in at $1.8 million for Q2 2026 at Beta Bionics, up from $623000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $15.6 million in Q1 2025 to a low of $6000.0 in Q1 2024.
• Average Other financing activities over 3 years is $2.6 million, with a median of $40000.0 recorded in 2024.
• Year-over-year, Other financing activities soared 259750.0% in 2025 and slumped 96.0% in 2026.
• Over 3 years, Other financing activities stood at $37000.0 in 2024, then surged by 42037.84% to $15.6 million in 2025, then plunged by 88.45% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $1.8 million in Q2 2026, $623000.0 in Q1 2026, and $15.6 million in Q1 2025.